Figure 2.
Estimated probability of abstinence throughout the 30-weeks of treatment for participants by treatment condition and Titrator or Completer attendance patterns. The analysis indicated an attendance pattern by treatment condition interaction at the end of treatment and at 6-month follow-up such that only Titrators in the control condition had significantly lower probability of quit success. ASI was centered at high ASI (ASI=23).